Vivos Therapeutics (VVOS) FCF Margin Growth (3y) (2023 - 2026)
Powered by 
Analysis
Vivos Therapeutics (VVOS) FCF Margin Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 10.93 Bn | 9.83 Bn | 757.43 Mn | -441.00 |
| 2 | Envista Holdings | 4.32 Bn | 3.20 Bn | 407.00 Mn | 507.00 |
| 3 | Dentsply Sirona | 2.14 Bn | 1.90 Bn | 493.00 Mn | -78.00 |
| 4 | Milestone Scientific | 37.15 Mn | 34.54 Mn | 1.56 Mn | 8,173.00 |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | - |
| 6 | Vivos Therapeutics | 3.22 Mn | 1.42 Mn | 2.95 Mn | 2,151.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,151.00 |
| Mar 31, 2026 | -1,930.00 |
| Dec 31, 2025 | -13,277.00 |
| Sep 30, 2025 | 7,955.00 |
| Jun 30, 2025 | 1,126.00 |
| Mar 31, 2025 | 4,065.00 |
| Dec 31, 2024 | 1,962.00 |
| Sep 30, 2024 | -1,581.00 |
| Jun 30, 2024 | 3,388.00 |
| Mar 31, 2024 | 4,270.00 |
| Dec 31, 2023 | 2,327.00 |
| Sep 30, 2023 | -6,863.00 |
| Jun 30, 2023 | -6,219.00 |
| Mar 31, 2023 | -8,412.00 |